×

Dihydropyrimido fused ring derivative as HBV inhibitor

  • US 9,938,301 B2
  • Filed: 05/27/2015
  • Issued: 04/10/2018
  • Est. Priority Date: 05/30/2014
  • Status: Active Grant
First Claim
Patent Images

1. A compound represented by formula (I) or a pharmaceutically acceptable salt thereof,

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×